GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Onconova Therapeutics ONTX · USD

Health Care · US listing · 🇺🇸 United States

Compare

6.38

+24.61%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Onconova Therapeutics

Our reporting

Past results

Reported against what analysts expected

14 Nov 202211 Aug 202211 May 202217 Mar 202211 Nov 202112 Aug 2021
Earnings per share-0.26-0.19-0.20-0.15-0.22-0.27
Forecast-0.22-0.20-0.19-0.28-0.33-0.29
Revenue$57,000$57,000$56,000$56,000$57,000$57,000
Forecast$58,616$58,108$86,609$60,392$54,129$20,299

Key events

  1. 23 Sept 202425-to-1 reverse split
  2. 21 May 202115-to-1 reverse split
  3. 26 Sept 201815-to-1 reverse split
  4. 1 Jun 201610-to-1 reverse split
  5. 25 Jul 2013Listed

Onconova Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.